Li Fu

Li Fu is an Associate Research Scientist in the Department of Neuroscience at Yale University, where her research focuses on the molecular and cellular mechanisms of neurodegenerative diseases. Her work centers on understanding how pathological protein aggregation, neuroinflammation, and synaptic dysfunction contribute to disease progression, using advanced approaches such as single-cell and single-nucleus RNA sequencing.

Prior to Yale, Li earned her Ph.D. at Okayama University in Japan, where she studied the therapeutic effects of anti-HMGB1 monoclonal antibody in a pilocarpine-induced status epilepticus mouse model. She later worked as a postdoctoral researcher at the Hong Kong University of Science and Technology, contributing to novel Alzheimer’s disease drug development